Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Sana Hasan"'
Autor:
Amanda Salih, Amanda Brown, Amanda Grimes, Sana Hasan, Manuel Silva-Carmona, Leyat Tal, Joud Hajjar
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Common variable immunodeficiency (CVID) can be complicated by granulomatous disease, often granulomatous lymphocytic interstitial lung disease (GLILD). Granulomatous interstitial nephritis represents an atypical presentation in pediatrics. Our patien
Externí odkaz:
https://doaj.org/article/d83633cbb3684891930bdd7c4818fb9a
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 29, Iss , Pp 100301- (2022)
Cystic fibrosis (CF) is an autosomal recessive disorder, with a prevalence of 1 in 2,500 live births. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. With the significant advancement in CFTR-directed
Externí odkaz:
https://doaj.org/article/4c189030a0e44fec927462e9fdf5837c
Autor:
Marcio L. Griebeler, Kevin M. Pantalone, Ron Gambino, David Shewmon, Jay Morrow, Daniel Mendlovic, Vinni Makin, Marwan Hamaty, Sana Hasan, M. Cecilia Lansang, Keren Zhou, Bartolome Burguera
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 7, Iss 1, Pp 1-4 (2021)
Abstract The COVID-19 pandemic has rapidly changed the landscape of medical care and the healthcare system needs to quickly adapt in order to continue providing optimal medical care to hospitalized patients in an efficient, effective, and safe manner
Externí odkaz:
https://doaj.org/article/cf794339a4cd4a62ba341c84c1357d79
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 27, Iss , Pp 100286- (2022)
The development and introduction of modulator therapies have completely shifted the paradigm for the treatment of cystic fibrosis (CF). Highly effective modulator therapies have driven marked improvements in lung function, exacerbation rate, weight a
Externí odkaz:
https://doaj.org/article/7fea1277f2a44a62904aa6445a6b8a91
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 27, Iss , Pp 100287- (2022)
Cystic fibrosis related diabetes (CFRD) generally reflects insufficient and/or delayed production of insulin, developing slowly over years to decades. Multiple mechanisms have been implicated in the pathogenesis of CFRD. CFTR function itself is a str
Externí odkaz:
https://doaj.org/article/445624c58b0f46ffac18c8a839f85e60
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 26, Iss , Pp 100268- (2021)
The novel SARS-CoV-2 coronavirus (COVID-19) has become a global health crisis since its initial outbreak in Wuhan, China in December 2019. On January 30, 2020, the WHO recognized the COVID-19 outbreak as a Public Health Emergency, and on March 11, 20
Externí odkaz:
https://doaj.org/article/690bad65dbe04d54aae2268901f86fa6
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 26, Iss , Pp 100273- (2021)
Vitamin D deficiency is common in the general population, and even more so in patients with cystic fibrosis. Deficiency is exacerbated in cystic fibrosis patients because of a myriad of causes including malabsorption, decreased fat mass, reduced 25-h
Externí odkaz:
https://doaj.org/article/035b608bb2f14e5db85b4a9ac6b363e4
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 23, Iss , Pp 100253- (2021)
Coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020. In efforts to reduce the risk of transmission, telehealth visits for routine care has significantly increased in the United States. Cystic fibrosis patients have been cate
Externí odkaz:
https://doaj.org/article/36eeee0138ad4f8b8f128178657ef888
Publikováno v:
Frontiers in Public Health, Vol 8 (2020)
The objective of this study is to compare the epidemiological variations in COVID-19 patients reported in studies from inside and outside of China. We selected COVID-19 observational studies from eight countries, including, China, Italy, Australia, C
Externí odkaz:
https://doaj.org/article/135a7ee846be4fe5ac22c8ee5cf379b2
Publikováno v:
Frontiers in Pediatrics, Vol 4 (2016)
X-linked agammaglobulinemia (XLA) is an X-linked inherited disease usually caused by a germline mutation in the BTK gene leading to Bruton’s tyrosine kinase deficiency, which results in the impaired development of B-lymphocytes and a subsequent lac
Externí odkaz:
https://doaj.org/article/c886e24b0bc645a882abdc1182fd0329